ECSP088489A - Prodrogas de sulfonato de sulfamoilo - Google Patents
Prodrogas de sulfonato de sulfamoiloInfo
- Publication number
- ECSP088489A ECSP088489A EC2008008489A ECSP088489A ECSP088489A EC SP088489 A ECSP088489 A EC SP088489A EC 2008008489 A EC2008008489 A EC 2008008489A EC SP088489 A ECSP088489 A EC SP088489A EC SP088489 A ECSP088489 A EC SP088489A
- Authority
- EC
- Ecuador
- Prior art keywords
- sulfamoil
- production
- sulfonate products
- sulfonate
- products
- Prior art date
Links
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000003846 Carbonic anhydrases Human genes 0.000 abstract 1
- 108090000209 Carbonic anhydrases Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- UYSRSLSTXYYNEW-UHFFFAOYSA-N NS(=O)(=O)S(O)(=O)=O Chemical compound NS(=O)(=O)S(O)(=O)=O UYSRSLSTXYYNEW-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005057408A DE102005057408A1 (de) | 2005-11-30 | 2005-11-30 | Sulfamoylsulfonat-Prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP088489A true ECSP088489A (es) | 2008-06-30 |
Family
ID=37983623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2008008489A ECSP088489A (es) | 2005-11-30 | 2008-05-30 | Prodrogas de sulfonato de sulfamoilo |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1957513A2 (pt) |
| JP (1) | JP2009517424A (pt) |
| KR (1) | KR20080072956A (pt) |
| CN (1) | CN101316858A (pt) |
| AU (1) | AU2006319380A1 (pt) |
| BR (1) | BRPI0619253A2 (pt) |
| CA (1) | CA2632272A1 (pt) |
| CR (1) | CR10003A (pt) |
| DE (1) | DE102005057408A1 (pt) |
| EA (1) | EA200801306A1 (pt) |
| EC (1) | ECSP088489A (pt) |
| IL (1) | IL191570A0 (pt) |
| NO (1) | NO20082915L (pt) |
| WO (1) | WO2007062874A2 (pt) |
| ZA (1) | ZA200805659B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293783B2 (en) * | 2009-03-24 | 2012-10-23 | National University Of Singapore | Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (COPD) |
| CN101987104A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物 |
| CN101987101A (zh) * | 2009-08-05 | 2011-03-23 | 天津金耀集团有限公司 | 糖皮质激素芳香基氨磺酰基磺酸酯为活性成分的眼用抗炎组合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10027887A1 (de) * | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE102004025966A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estradiol-Prodrugs |
| DE102004025985A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estriol- und Estetrol-Prodrugs |
| DE102004025986A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Steroid-Prodrugs mit androgener Wirkung |
-
2005
- 2005-11-30 DE DE102005057408A patent/DE102005057408A1/de not_active Ceased
-
2006
- 2006-11-27 WO PCT/EP2006/011726 patent/WO2007062874A2/de not_active Ceased
- 2006-11-27 BR BRPI0619253-0A patent/BRPI0619253A2/pt not_active Application Discontinuation
- 2006-11-27 JP JP2008542678A patent/JP2009517424A/ja active Pending
- 2006-11-27 AU AU2006319380A patent/AU2006319380A1/en not_active Abandoned
- 2006-11-27 CA CA002632272A patent/CA2632272A1/en not_active Abandoned
- 2006-11-27 CN CNA2006800449086A patent/CN101316858A/zh active Pending
- 2006-11-27 EP EP06829354A patent/EP1957513A2/de not_active Withdrawn
- 2006-11-27 KR KR1020087015775A patent/KR20080072956A/ko not_active Withdrawn
- 2006-11-27 EA EA200801306A patent/EA200801306A1/xx unknown
-
2008
- 2008-05-20 IL IL191570A patent/IL191570A0/en unknown
- 2008-05-21 CR CR10003A patent/CR10003A/es not_active Application Discontinuation
- 2008-05-30 EC EC2008008489A patent/ECSP088489A/es unknown
- 2008-06-27 ZA ZA200805659A patent/ZA200805659B/xx unknown
- 2008-06-27 NO NO20082915A patent/NO20082915L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007062874B1 (de) | 2007-09-27 |
| CN101316858A (zh) | 2008-12-03 |
| EP1957513A2 (de) | 2008-08-20 |
| CA2632272A1 (en) | 2007-06-07 |
| KR20080072956A (ko) | 2008-08-07 |
| CR10003A (es) | 2008-08-21 |
| AU2006319380A1 (en) | 2007-06-07 |
| WO2007062874A3 (de) | 2007-07-12 |
| JP2009517424A (ja) | 2009-04-30 |
| WO2007062874A2 (de) | 2007-06-07 |
| ZA200805659B (en) | 2009-10-28 |
| EA200801306A1 (ru) | 2008-10-30 |
| IL191570A0 (en) | 2008-12-29 |
| DE102005057408A1 (de) | 2007-05-31 |
| BRPI0619253A2 (pt) | 2011-09-27 |
| NO20082915L (no) | 2008-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2006000193A (es) | Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso | |
| UY29919A1 (es) | Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones | |
| ECSP099044A (es) | Compuestos de pirimido fusionados | |
| UY28747A1 (es) | Nuevo proceso para la sintesis y nueva forma cristalina de agomelatina y composiciones farmaceuticas que las contienen | |
| UY30025A1 (es) | Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
| UY29530A1 (es) | Compuestos quimicos | |
| CR10696A (es) | Compuestos de n-metilaminometil isoindol, composiciones que las comprenden y metodos que utilizan los mismos | |
| UY29479A1 (es) | Inhibidores de adn-pk | |
| CU20090070A7 (es) | Nuevos derivados de sulfonamida como antagonistas de la bradiquinina | |
| UY30709A1 (es) | Nuevos derivados de 1,4-benzotiepina-1, 1-dioxido sustituidos con radicales bencilo, método para su preparacion, productos farmacéuticos que comprenden estos compuestos y su uso. | |
| ECSP077271A (es) | Derivados de pirimidina | |
| CR10479A (es) | Modulares bencimidazolicos de vr1 | |
| PA8796201A1 (es) | Agentes anti-infecciosos y su uso | |
| CO6280399A2 (es) | Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i | |
| ECSP066914A (es) | FORMA CRISTALINA dd DEL CLORHIDRATO DE LA IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y LAS COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
| ECSP088221A (es) | Agonistas adrenoreceptores alfa2c | |
| ECSP078053A (es) | Nuevos derivados de 2-azetidinona útiles en el tratamiento de condiciones de hiperlipidemia | |
| ECSP077259A (es) | Derivados de pirimidina | |
| CU20060037A7 (es) | Forma cristalina gamma del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| CU23615B7 (es) | Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| BRPI0712889A8 (pt) | composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica. | |
| CR9391A (es) | Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| ECSP099389A (es) | Nuevas formas cristalinas | |
| UY29607A1 (es) | Compuestos quimicos | |
| AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden |